ATHENEX - CHINA API BUSINESS
Athenex - China API Business engages in Active Pharmaceutical Ingredient (API) manufacturing operations.
Similar Organizations
Aun herbal remedies
Aun Herbal Remedies is a reputated Unani and Ayurvedic manufacturing & Herbal products
Libra Group
Libra Group is a pharmaceutical and medicine manufacturing company.
Saraca Laboratories
Saraca Laboratories is a pharmaceutical ingredients manufacturer.
More informations about "Athenex - China API Business"
Athenex Announces Entry into Agreement to Sell its China
Nov 7, 2022 Athenex Announces Entry into Agreement to Sell its China API Business to TiHe Capital (Bejing) Co., Ltd. July 11, 2022 08:00 ET | Source: Athenex, Inc. Athenex, Inc.See details»
Athenex Announces Entry into Agreement to Sell its China API …
Jul 11, 2022 Athenex, Inc. Expected sale proceeds of approximately $19.0 million. Company continues to monetize non-core assets to extend cash runway. Proceeds from the deal will be …See details»
Athenex Announces Closing of the Sale of its China API
Nov 21, 2022 Athenex also entered into a long-term supply agreement with entities controlled by Chongqing Comfort for the supply of APIs needed for Athenex’s small molecule drug products. …See details»
Athenex Announces Closing of the Sale of its China API Business
BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and …See details»
Athenex Announces Entry into Agreement to Sell its China API …
Jul 11, 2022 Athenex (NASDAQ: ATNX) announced plans to sell its China subsidiaries involved in Active Pharmaceutical Ingredient manufacturing to TiHe Capital for approximately $19 …See details»
Athenex Announces Closing of the Sale of its China API Business
Nov 22, 2022 Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related …See details»
Athenex - China API Business - Crunchbase
Athenex - China API Business engages in Active Pharmaceutical Ingredient (API) manufacturing operations.See details»
Athenex sells Chinese API business for $19 M - BioSpectrum Asia
Jul 12, 2022 Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related …See details»
Athenex Announces Entry into Agreement to Sell its China API …
Proceeds from the transaction will be used in part toward repaying existing debt and operating the business. The deal is subject to customary closing conditions, including obtaining certain …See details»
Athenex : Announces Entry into Agreement to Sell its China API …
Buffalo, N.Y., July 11, 2022 (GLOBE NEWSWIRE) - Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization …See details»
Athenex - China API Business - Products, Competitors, Financials ...
Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for …See details»
Athenex Announces Closing of the Sale of its China API Business
BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., ( ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization …See details»
Athenex Announces Entry into Agreement to Sell its China API …
BUFFALO, N.Y., July 11, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and …See details»
Athenex Announces Closing of the Sale of its China API Business
Nov 21, 2022 Athenex, Inc. today announced the closing of the sale of its equity interests in its China subsidiaries, which primarily represent the Company’s ownership of its active …See details»
Athenex Announces Entry into Agreement to Sell its China API …
Jul 11, 2022 Expected sale proceeds of approximately $19.0 millionCompany continues to monetize non-core assets to extend cash runwayProceeds from the deal will be used to pay …See details»
Athenex Announces Closing of the Sale of its China API Business
Nov 21, 2022 Athenex Announces Closing of the Sale of its China API Business GlobeNewswire November 21, 2022 BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., …See details»
Athenex Announces Entry into Agreement to Sell its China API …
Breaking News: Athenex Announces Entry into Agreement to Sell its China API Business to TiHe Capital (Bejing) Co., Ltd.GlobeNewswireJuly 11, 2022Expected sale proceeds of …See details»
Athenex Announces Closing of the Sale of its China API Business
Nov 21, 2022 Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for theSee details»
Athenex - China API Business - Updates, News, Events
Athenex - China API Business engages in Active Pharmaceutical Ingredient (API) manufacturing operations.See details»